Transforming Industrial CO₂ into High-Value Bioproducts
The CO₂ Paradox
A Hibernating Asset
CO₂ is treated as a problem, not a resource
Industries spend over $200 billion annually managing CO₂ as waste, even though it’s a carbon-rich feedstock for chemicals, materials, and proteins. Solmeyea turns this “waste” into real value.
Sources: World Bank (2024-2025), McKinsey (2022)
Carbon markets and incentives are broken
While $2 trillion in green finance exists, most carbon projects only reduce costs rather than generate revenue. Investors need returns, but CO₂ projects fail to deliver them.
Sources: McKinsey & Company (2022), Climate Policy Initiative (2025)
Stranded assets and linear thinking
Over $1 trillion in fossil infrastructure faces obsolescence. Meanwhile, 90% of materials in the economy remain fossil-derived. Current approaches like “reduce, reuse, recycle” do not address upstream carbon.
Sources: Semieniuk, G., et al. (2022), Nature Climate Change, IEA (2018)
Europe’s Timing Pressure
Supply Chains Under Pressure
Dependence on imported food and materials exposes European industries to price volatility and regulatory risk.
Competitiveness at risk
The EU’s Carbon Border Adjustment Mechanism (CBAM) protects industry but raises import costs, accelerating the need for domestic low-carbon production.
2030 deadlines demand immediate solutions
EU Green Deal, Paris Agreement, and corporate net-zero pledges require scalable solutions today, not unsubstantiated promises for the future.

